Loading...

Expansion Into Tier Two And Three Markets Will Improve Healthcare

Published
24 Feb 25
Updated
05 Sep 25
AnalystConsensusTarget's Fair Value
₹1,693.60
19.6% undervalued intrinsic discount
05 Sep
₹1,361.80
Loading
1Y
-2.8%
7D
-4.0%

Author's Valuation

₹1.69k

19.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on05 Sep 25

With net profit margin and revenue growth forecasts both holding steady, analysts have left their fair value estimate for Rainbow Children's Medicare unchanged at ₹1694. What's in the News Company to hold a Special/Extraordinary Shareholders Meeting via postal ballot in India.

Shared on01 May 25
Fair value Increased 2.36%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 1.03%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 2.01%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on13 Mar 25
Fair value Increased 2.01%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.